Vor Biopharma Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vor Biopharma Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Vor Biopharma Inc. Return On Equity for the quarter ending June 30, 2024 was -86.4 %, a 71.8% decline year-over-year.
  • Vor Biopharma Inc. annual Return On Equity for 2023 was -62 %, a 31.1% decline from 2022.
  • Vor Biopharma Inc. annual Return On Equity for 2022 was -47.3 %, a 65.9% decline from 2021.
  • Vor Biopharma Inc. annual Return On Equity for 2021 was -28.5 %, a 127% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -62 -14.7 -31.1% Jan 1, 2023 Dec 31, 2023
2022 -47.3 -18.8 -65.9% Jan 1, 2022 Dec 31, 2022
2021 -28.5 -136 -127% Jan 1, 2021 Dec 31, 2021
2020 107 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.